Ewa Chmielowska
- Oncology top 10%
- Pulmonary and Respiratory Medicine
- Pathology and Forensic Medicine top 10%
- Molecular Biology
- Reproductive Medicine top 10%
- Co-authors
- A PłużańskaMaria Błasińska-MorawiecPiotr SmolewskiE KrykowskiTadeusz RobakJames A. WilliamsFrédèric SelleMaciej Krzakowski
- Topics
- Cancer Treatment and Pharmacology (10 papers)Lung Cancer Treatments and Mutations (8 papers)Lymphoma Diagnosis and Treatment (8 papers)
- Partner nations
- PolandUnited KingdomSpain
In The Last Decade
Ewa Chmielowska
40 papers receiving 462 citations
Peers
Comparison fields: 5 of 56
- Oncology 251
- Pulmonary and Respiratory Medicine 132
- Pathology and Forensic Medicine 119
- Molecular Biology 109
- Reproductive Medicine 70
Countries citing papers authored by Ewa Chmielowska
This map shows the geographic impact of Ewa Chmielowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Chmielowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Chmielowska more than expected).
Fields of papers citing papers by Ewa Chmielowska
This network shows the impact of papers produced by Ewa Chmielowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Chmielowska. The network helps show where Ewa Chmielowska may publish in the future.
Co-authorship network of co-authors of Ewa Chmielowska
This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Chmielowska. A scholar is included among the top collaborators of Ewa Chmielowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Chmielowska. Ewa Chmielowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 10 | |
| 8 | 55 | |
| 9 | The role of anthracyclines and dose dense therapy in an adjuvant setting, in HER2-positive early breast cancer, in clinical practice | 1 |
| 10 | Reshaping the Tradition: Postpartum Care in Modern Taiwan | 1 |
| 11 | 7 | |
| 12 | 5 | |
| 13 | 9 | |
| 14 | 1 | |
| 15 | 30 | |
| 16 | 38 | |
| 17 | 17 | |
| 18 | Safety and efficacy of interferon-alfa2b (IFN) in the treatment of patients with mycosis fungoides | 0 |
| 19 | Liposomal doxorubicin-induced cardiotoxicity — case report | 0 |
| 20 | 44 |
About Ewa Chmielowska
Ewa Chmielowska is a scholar working on Oncology, Dermatology and Pathology and Forensic Medicine, having authored 44 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Lymphoma Diagnosis and Treatment (8 papers). The work is most often cited by research in Oncology (251 citations), Reproductive Medicine (70 citations) and Pathology and Forensic Medicine (119 citations). Ewa Chmielowska has collaborated with scholars based in Poland, United Kingdom and Spain. Frequent co-authors include A Płużańska, Maria Błasińska-Morawiec, Piotr Smolewski, E Krykowski, Tadeusz Robak, James A. Williams, Frédèric Selle, Maciej Krzakowski, Mona Shing and Tara Fox. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.